Parasitic fungus Claviceps as a source for biotechnological production of ergot alkaloids

Biotechnology Advances

Volumn 31, Issue 1, 2013, Pages 79-89

  Hulvová, Helena ^a   Galuszka, Petr ^a   Frébortová, Jitka ^a   Frébort, Ivo ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Claviceps; Ergopeptine; Ergot alkaloids; Ergotamine; Lysergic acid

Indexed keywords

CLAVICEPS; ERGOPEPTINE; ERGOT ALKALOIDS; ERGOTAMINE; LYSERGIC ACID;

BIOCHEMISTRY; METABOLITES;

NITROGEN COMPOUNDS;

ENZYME; ERGOT ALKALOID;

ALKALOID; BIOCHEMISTRY; BIOLOGICAL PRODUCTION; BIOTECHNOLOGY; CEREAL; CULTIVATION; DRUG DEVELOPMENT; FERMENTATION; FUNGUS; GENETICS; INDUSTRIAL PRODUCTION; PARASITE; PHARMACEUTICAL INDUSTRY; TECHNOLOGICAL DEVELOPMENT;

BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; CLAVICEPS; FERMENTATION; GENETIC ENGINEERING; GENETICS; METABOLISM; METHODOLOGY; MICROBIOLOGY; REVIEW; RYE;

CLAVICEPS; ENZYMES; ERGOT ALKALOIDS; FERMENTATION; GENETIC ENGINEERING; INDUSTRIAL MICROBIOLOGY; MOLECULAR STRUCTURE; SECALE CEREALE;

CLAVICEPS; FUNGI; SECALE CEREALE;

EID: 84871932944     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.01.005     Document Type: Review

References (119)

1. Abe M., Yamatodani S., Yamano T., Kozu Y., Yamada S. Production of alkaloids and related substances by fungi. Examination of filamentous fungi for their ability of producing ergot alkaloids. J Agric Chem Soc Jpn 1967, 41:68-71.
2. Alm T. The witch trials of Finnmark, Northern Norway, during the 17th century: evidence for ergotism as a contributing factor. Econ Bot 2003, 57:403-416.
3. Arntz C., Tudzynski P. Identification of genes induced in alkaloid-producing cultures of Claviceps sp. Curr Genet 1997, 31:357-360.
4. Bayram Ö., Krappmann S., Ni M., Bok J.W., Helmstaedt K., Valerius O., et al. VelB/VeA/LaeA complex coordinates light signal with fungal development and secondary metabolism. Science 2008, 13:1504-1506.
5. Bok J.W., Keller N.P. LaeA, a regulator of secondary metabolism in Aspergillus spp. Eukaryot Cell 2004, 3:527-535.
6. Bonuccelli U., Del Dotto P., Rascol O. Role of dopamine receptor agonists in the treatment of early Parkinson's disease. Parkinsonism Relat Disord 2009, 15:44-53.
7. Bormann J., Tudzynski P. Deletion of Mid1, a putative stretch-activated calcium channel in Claviceps purpurea, affects vegetative growth, cell wall synthesis and virulence. Microbiology 2009, 155:3922-3933.
8. Bové F.J. The story of ergot 1970, S Karger, Basel.
9. Buchta M., Cvak L. Ergot alkaloids and other metabolites of the genus Claviceps. Ergot: the genus Claviceps 1999, 173-200. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
10. Caporael L.R. Ergotism: the Satan loosed in Salem?. Science 1976, 192:21-26.
11. Cheng L.J., Robbers J.E., Floss H.G. End-product regulation of ergot alkaloid formation in intact cells and protoplasts of Claviceps species, strain SD58. J Nat Prod 1980, 43:329-339.
12. Clay K., Schardl C. Evolutionary origins and ecological consequences of endophyte symbiosis with grasses. Am Nat 2002, 160:99-127.
13. Cole R.J., Kirskey J.W., Dorner J.W., Wilson D.M., Johnson J., Bedell D., et al. Mycotoxins produced by Aspergillus fumigatus isolated from silage. Ann Nutr Aliment 1977, 31:685-692.
14. Comino A., Kolar M., Schwab H., Sočič H. Heterologous transformation of Claviceps purpurea. Biotechnol Lett 1989, 11:389-392.
15. Correia T., Grammel N., Ortel I., Keller U., Tudzynski P. Molecular cloning and analysis of the ergopeptine assembly system in the ergot fungus Claviceps purpurea. Chem Biol 2003, 10:1281-1292.
16. Coyle C.M., Panaccione D.G. Abundant respirable ergot alkaloids from the common airborne fungus Aspergillus fumigatus. Appl Environ Microbiol 2005, 71:3112-3118.
17. Cunfer B.M. Inhibition of conidial germination by Claviceps purpurea honeydew fluid. Can J Bot 1976, 54:2541-2545.
18. Cvak L. Industrial production of ergot alkaloids. Ergot: the genus Claviceps 1999, 373-410. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
19. de Groot A.N., van Dongen P.W., Vree T.B., Hekster Y.A., van Roosmalen J. Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs 1998, 56:523-535.
20. Demeke T., Kidane Y., Wuhib E. Ergotism: a report on an epidemic. Ethiop Med J 1979, 17:107-113.
21. Dudley H.W., Moir C. The substance responsible for the traditional clinical effect of ergot. Br Med J 1935, 1:520-523.
22. Dumas P., Bergdoll M., Cagnon C., Masson J.M. The three-dimensional structure of a bleomycin resistance protein. EMBO J 1994, 242:595-601.
23. Eadie M.J. Convulsive ergotism: epidemics of the serotonin syndrome?. Lancet Neurol 2003, 2:429-434.
24. El-Refai A.M.H., Sallam L.A.R., Naim N. The alkaloids of fungi I. The formation of ergoline alkaloids by representative mold fungi. Jpn J Microbiol 1970, 45:581-585.
25. Emilien G., Maloteaux J.M., Geurts M., Hoogenberg K., Cragg S. Dopamine receptors-physiological understanding to therapeutic intervention potential. Pharmacol Ther 1999, 84:133-156.
26. Engelenburg F., Smit R., Goosen T., Broek H., Tudzynski P. Transformation of Claviceps purpurea using a bleomycin resistance gene. Appl Microbiol Biotechnol 1989, 30:364-370.
27. Esser K., Düvell A. Biotechnological exploitation of ergot fungus (Claviceps purpurea). Proc Biochem 1984, 19:142-149.
28. Flieger M., Mehta P., Mehta A. Biotechnological potential of ergot alkaloids. Fungal biotechnology in agricultural, food, and environmental applications 2004, 150-165. Marcel Dekker, New York. D.K. Arora (Ed.).
29. Floss H.G. From ergot to ansamycins - 45years in biosynthesis. J Nat Prod 2006, 69:158-169.
30. Galagan J.E., Calvo S.E., Cuomo C., Ma L.J., Wortman J.R., Batzoglou S., et al. Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 2005, 438:1105-1115.
31. Gebler J.C., Poulter D. Purification and characterization of dimethylallyl tryptophan synthase from Claviceps purpurea. Arch Biochem Biophys 1992, 296:308-313.
32. Geiger H.H., Miedaner T. Rye breeding. Cereals: handbook of plant breeding 2009, 157-181. Springer Science, New York. M.J. Carena (Ed.).
33. Giesbert S., Schürg T., Scheele S., Tudzynski P. The NADPH oxidase Cpnox1 is required for full pathogenicity of the ergot fungus Claviceps purpurea. Mol Plant Pathol 2008, 9:317-327.
34. Glatt H., Eich E., Pertz H., Becker C., Oesch F. Mutagenicity experiments on agroclavines, new natural antineoplastic compounds. Cancer Res 1987, 47:1811-1814.
35. Goetz KE. Characterization of a catalase gene associated with ergot alkaloids in Aspergillus fumigatus, and studies on an alternate lysergyl peptide synthetase gene and ergopeptine in Neotyphodium coenophialum. Diploma thesis, West Virginia University, USA, 2008.
36. Goetz K.E., Coyle C.M., Cheng J.Z., O'Connor S.E., Panaccione D.G. Ergot cluster-encoded catalase is required for synthesis of chanoclavine-I in Aspergillus fumigatus. Curr Genet 2011, 57:201-211.
37. Görnemann T., Jähnichen S., Schurad B., Latté K.P., Horowski R., Tack J., et al. Pharmacological properties of a wide array of ergolines at functional alpha1-adrenoceptor subtypes. Naunyn-Schmiedebergs Arch Pharmacol 2008, 376:321-330.
38. Gröger D., Floss H.G. Biochemistry of ergot alkaloids-achievements and challenges. The alkaloids-chemistry and biology 1998, 171-218. Academic Press, New York. G.A. Cordell (Ed.).
39. Gröger D., Erge D., Floss H.G. Biosynthese der Mutterkornalkaloide Einbau von Chanoklavin I in Ergolin-Derivate. Z Naturforsch 1966, 21:827-832.
40. Groot M.J.A., Bundock P., Hooykaas P.J.J., Beijersbergen A.G.M. Agrobacterium tumefaciens-mediated transformation of filamentous fungi. Nat Biotechnol 1998, 16:839-842.
41. Haarmann T., Tudzynski P. The alkaloid pathway and evolution of chemical races in Claviceps purpurea. 8th European Conference on Fungal Genetics, Vienna, Austria, April 8-11, 2006; Abstracts 2006, 408.
42. Haarmann T., Machado C., Lübbe Y., Correia T., Schardl C.L., Pannacione D.G., et al. The ergot alkaloid gene cluster in Claviceps purpurea: extension of the cluster sequence and intra species evolution. Phytochemistry 2005, 66:1312-1320.
43. Haarmann T., Ortel I., Tudzynski P., Keller U. Identification of the cytochrome P450 monooxygenase that bridges the clavine and ergoline alkaloid pathways. Chembiochem 2006, 7:645-652.
44. Haarmann T., Rolke Y., Giesbert S., Tudzynski P. Ergot: from witchcraft to biotechnology. Mol Plant Pathol 2009, 10:563-577.
45. Hadley G. Development of stromata in Claviceps purpurea. Trans Br Mycol Soc 1968, 51:763-769.
46. Hulvová H., Jaroš M., Kubesa V., Galuszka P. Genetic modification of Claviceps purpurea for increasing the contents of ergot alkaloids. X International Fungal Biology Conference "Frontiers in Fungal Biology", Ensenada, Baja California, Mexico, December 6-10, 2009; Abstracts 2009, 132.
47. Hulvová H., Kubesa V., Jaroš M., Galuszka P. Affecting of ergot alkaloid production in Claviceps purpurea by genetic manipulation. IMC9 - The Biology of Fungi, Edinburg, UK, August 1-6, 2010; Abstracts 2010, 4.187.
48. Innes I.R. Identification of the smooth muscle excitatory receptor for ergot alkaloids. Br J Pharmacol 1962, 19:120-128.
49. Keller U. Biosynthesis of ergot alkaloids. Ergot: the genus Claviceps 1999, 95-164. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
50. Keller U., Zocher R., Kleinkauf H. Biosynthesis of ergotamine in protoplasts of Claviceps purpurea. J Gen Microbiol 1980, 118:485-494.
51. Kirchhoff H. Beiträge zur Biologie und Physiologie des Mutterkornpilzes. Centralblat Bakteriol Parasitenk Abt II 1929, 77:310-369.
52. Kobel H., Sanglier J.J. Ergot alkaloids. Biotechnology 1986, 569-609. VCB, Weinheim. H.J. Rehm, G. Reed (Eds.).
53. Křen V., Harazim P., Malinka Z. Claviceps purpurea (ergot): culture and bioproduction of ergot alkaloids. Biotechnology in agriculture and forestry, medicinal and aromatic plants 1994, 139-156. Springer-Verlag, Berlin. Y.P.S. Bajaj (Ed.).
54. Krupinski V.M., Robbers J.E., Floss H.G. Physiological study of ergot: induction of alkaloid synthesis by tryptophan at the enzymatic level. J Bacteriol 1976, 125:158-165.
55. Kybal J., Vlček V. A simple device for stationary cultivation of microorganisms. Biotechnol Bioeng 1976, 18:1713-1718.
56. Lee M.R. The history of ergot of rye (Claviceps purpurea) I: from antiquity to 1900. J R Coll Physicians Edinb 2009, 39:179-184.
57. Liu M., Panaccione D.G., Schardl C.L. Phylogenetic analyses reveal monophyletic origin of the ergot alkaloid gene dmaW in fungi. Evol Bioinform 2009, 5:15-30.
58. Lorenz N., Wilson E.V., Machado C., Schardl C.L., Tudzynski P. Comparison of ergot alkaloid biosynthesis gene clusters in Claviceps species indicates loss of late pathway steps in evolution of C. fusiformis. Appl Environ Microbiol 2007, 73:7185-7191.
59. Lorenz N., Haarmann T., Pažoutová S., Jung M., Tudzynski P. The ergot alkaloid gene cluster: functional analyses and evolutionary aspects. Phytochemistry 2009, 70:1822-1832.
60. Lorenz N., Olšovská J., Šulc M., Tudzynski P. Alkaloid cluster gene ccsA of the ergot fungus Claviceps purpurea encodes chanoclavine I synthase, a flavin adenine dinucleotide-containing oxidoreductase mediating the transformation of N-methyl-dimethylallyltryptophan to chanoclavine I. Appl Environ Microbiol 2010, 76:1822-1830.
61. Loveless A.R. Conidial evidence for host restriction in Claviceps purpurea. Trans Br Mycol Soc 1971, 56:419-434.
62. Maier H.W. L'ergotamine, inhibiteur du sympathique etudie en clinque, comme moyen d'exploration et comme agent therapeutique. Rev Neurol 1926, 33:1104-1108.
63. Malinka Z. Saprophytic cultivation of Claviceps. Ergot: the genus Claviceps 1999, 321-371. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
64. Mantle P.G., Waight E.S. Dihydroergosine: a new naturally occurring alkaloid from the sclerotia of Sphacelia sorghi (McRae). Nature 1968, 218:581-582.
65. Markert A., Steffan N., Ploss K., Hellwig S., Steiner U., Drewke C., et al. Biosynthesis and accumulation of ergoline alkaloids in a mutualistic association between Ipomoea asarifolia (Convolvulaceae) and a clavicipitalean fungus. Plant Physiol 2008, 147:296-305.
66. Matuschek M., Wallwey C., Xie X., Li S.M. New insights into ergot alkaloid biosynthesis in Claviceps purpurea: an agroclavine synthase EasG catalyses, via a non-enzymatic adduct with reduced glutathione, the conversion of chanoclavine-I aldehyde to agroclavine. Org Biomol Chem 2011, 9:4328-4335.
67. Mey G., Held K., Scheffer J., Tenberge K.B., Tudzynski P. CPMK2, an SLT2-homologous mitogen-activated protein (MAP) kinase, is essential for pathogenesis of Claviceps purpurea on rye: evidence for a second conserved pathogenesis-related MAP kinase cascade in phytopathogenic fungi. Mol Microbiol 2002, 46:305-318.
68. Meyer V., Mueller D., Strowig T., Stahl U. Comparison of different transformation methods for Aspergillus giganteus. Curr Genet 2003, 43:371-377.
69. Michielse C.B., Hooykas P.J., van den Hondel C.A., Ram A.F. Agrobacterium-mediated transformation as a tool for functional genomics in fungi. Curr Genet 2005, 48:1-17.
70. Minghetti A., Crespi-Perellino N. The history of ergot. Ergot: the genus Claviceps 1999, 1-24. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
71. Mullins E.D., Chen X., Romaine P., Raina R., Geiser D.M., Kang S. Agrobacterium-mediated transformation of Fusarium oxysporum: an efficient tool for insertional mutagenesis and gene transfer. Phytopathology 2001, 91:173-180.
72. Naim N. Alkaloid production by some local fungi. Zentralbl Bakteriol II 1980, 135:715-720.
73. Narayan V., Rao K.K. Factors affecting the fermentation of ergot alkaloids by Aspergillus fumigatus (Fresenius). Biotechnol Lett 1982, 4:193-196.
74. Nasr H., Pearson O.H. Inhibition of prolactin secretion by ergot alkaloids. Acta Endocrinol 1975, 80:429-443.
75. Nathues E., Joshi S., Tenberge K.B., von den Driesch M., Oeser B., Bäumer N., et al. CPTF1, a CREB-like transciption factor is involved in the oxidative stress response in the phytopathogen Claviceps purpurea and modulates ROS level in its host Secale cereale. Mol Plant Microbe-Interact 2004, 17:383-393.
76. Nathues E., Jörgens C., Lorenz N., Tudzynski P. The fungal histidin kinase CpHK2 has impact on spore germination, oxidative stress and fungicide resistance, and virulence of the ergot fungus Claviceps purpurea. Mol Plant Pathol 2007, 8:653-665.
77. Németh E. Parasitic production of ergot alkaloids. Ergot: the genus Claviceps 1999, 303-320. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
78. Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J., et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 2005, 438:1151-1156.
79. Oeser B., Heidrich P., Müller U., Tudzynski P., Tenberge K.B. Polygalacturonase is a pathogenicity factor in the Claviceps purpurea/rye interaction. Fungal Genet Biol 2002, 36:176-186.
80. Oeser B., Beaussart F., Haarmann T., Lorenz N., Nathues E., Rolke Y., Scheffer J., Weiner J., Tudzynski P. Mol Plant Pathol 2009, 10:665-684.
81. Ortel I., Keller U. Combinatorial assembly of simple and complex d-lysergic acid alkaloid peptide classes in the ergot fungus Claviceps purpurea. J Biol Chem 2009, 284:6650-6660.
82. Otsuka H., Quigley F.R., Gröger D., Anderson J.A., Floss H.G. In vivo and in vitro evidence for N-methylation as the second pathway-specific step in ergoline biosynthesis. Planta Med 1980, 40:109-119.
83. Parbery D.G. Tropism and the ecology of fungi associated with plants. Biol Rev 1996, 71:473-527.
84. Pažoutová S., Parbery D.P. The taxonomy and phylogeny of Claviceps. Ergot: the genus Claviceps 1999, 57-77. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
85. Pažoutová S., Olšovská J., Linka M., Kolínská R., Flieger M. Chemoraces and habitat specialization of Claviceps purpurea populations. Appl Environ Microbiol 2000, 66:5419-5425.
86. Pertz H., Eich E. Ergot alkaloids and their derivatives as ligands for serotoninergic, dopaminergic, and adrenergic receptors. Ergot: the genus Claviceps 1999, 411-440. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
87. Popelka J.C., Altpeter F. Agrobacterium tumefaciens-mediated genetic transformation of rye (Secale cereale L.). Mol Breed 2003, 11:203-211.
88. Ramstad E., Gjerstad G. The parasitic growth of Claviceps purpurea (Fries) tulasne on rye and its relation to alkaloid formation. J Am Pharm Assoc 1955, 44:741-743.
89. Rehmeyer C., Li W., Kusaba M., Kim Y.S., Brown D., Staben C., et al. Organization of chromosome ends in the rice blast fungus, Magnoporthe oryzae. Nucleic Acids Res 2006, 34:4685-4701.
90. Robbers J.E. The fermentative production of ergot alkaloids. Adv Biotechnol Processes 1984, 3:197-239.
91. Rolke Y., Tudzynski P. The small GTPase Rac and the PAKkinase Cla4 in Claviceps purpurea: interaction and impact on polarity, development and pathogenicity. Mol Microbiol 2008, 68:405-423.
92. Rucman R. Lysergsäure. II. Isolation und Trennung der Lysergsäuren. J Chromatogr 1976, 121:353-360.
93. Scheffer J., Chen C., Heidrich P., Dickman M.B., Tudzynski P. A CDC42 homologue in Claviceps purpurea is involved in vegetative differentiation and is essential for pathogenicity. Eukaryot Cell 2005, 4:1228-1238.
94. Schiff P.L. Ergot and its alkaloids. Am J Pharm Educ 2006, 70:98-107.
95. Schwarz G., Eich E. Influence of ergot alkaloids on growth of Streptomyces purpurascens and production of its secondary metabolites. Planta Med 1983, 7:212-214.
96. Silberstein S.D., Saper J., Frietag F. Migraine: diagnosis and treatment. Wolff's headache and other head pain 2001, 121-237. Oxford University Press, New York. 7th ed. S.D. Silberstein, R.B. Lipton, D.J. Dalessio (Eds.).
97. Smit R., Tudzynski P. Efficient transformation of Claviceps purpurea using pyrimidine auxotrophic mutants: cloning of the OMP decarboxylase gene. Mol Gen Genet 1992, 234:297-305.
98. Sočič H., Gaberc-Porekar V. Biosynthesis and physiology of ergot alkaloids. Handbook of applied mycology: fungal biotechnology 1992, 475-515. Dekker, New York. D.K. Arora, R.P. Elander, K.G. Mukerji (Eds.).
99. Spalla C. Genetic problems of production of ergot alkaloids in saprophytic and parasitic conditions. Genetics of industrial microorganisms 1973, 393-403. Elsevier, Amsterdam. Z. Vaněk, Z. Řeháček, J. Cudlin (Eds.).
100. Spanos N.P., Gottlieb J. Ergotism and the Salem village witch trials. Science 1976, 194:1390-1394.
101. Spilbury J.F., Wilkinson S. The isolation of festuclavine and two new clavine alkaloids from Aspergillus fumigatus Fres. J Chem Soc 1961, 5:2085-2091.
102. Steiner U., Ahimsa-Müller M.A., Markert A., Kucht S., Groß J., Kauf N., et al. Molecular characterization of a seed transmitted clavicipitaceous fungus occurring on dicotyledoneous plants (Convolvulaceae). Planta 2006, 224:533-544.
103. Steiner U., Leibner S., Schardl C.L., Leuchtman A., Leistner E. Periglandula, a new fungal genus within the Clavicipitaceae and its association with Convolvulaceae. Mycologia 2011, 103:1133-1145.
104. Stinnett S.M., Espeno E.A., Cobeño L., Araújo-Bazán L., Calvo A.M. Aspergillus nidulans VeA subcellular localization is dependent on the importin alpha carrier and on light. Mol Microbiol 2007, 63:242-255.
105. Stoll A. Über Ergotamin (10. Mitteilung über Mutterkornalkaloide). Helv Chim Acta 1945, 28:1283-1308.
106. Swan D.J., Mantle P.G. Parasitic interactions between Claviceps purpurea strains in wheat and an acute necrotic host response. Mycol Res 1991, 95:807-810.
107. Taber W.A. Biology of Claviceps. Biology of industrial microorganism 1985, 449-486. The Benjamin Cummings Publishing Company, San Francisco. A.L. Demain, N.A. Solomon (Eds.).
108. Tenberge K.B. Biology of ergot fungi. Ergot: the genus Claviceps 1999, 25-56. Harwood Academic Publishers, Amsterdam. V. Křen, L. Cvak (Eds.).
109. Thoms H. John Stearns and pulvis parturiens. Am J Obstet Gynecol 1931, 22:418-423.
110. Tomsett A.B., Dunn-Coleman N.S., Garrett R.H. The regulation of nitrate assimilation in Neurospora crassa: the isolation and genetic analysis of nmr-1 mutants. Mol Gen Genet 1981, 182:229-233.
111. Tsai H.F., Wang H., Gebler J.C., Poulter C.D., Schardl C.L. The Claviceps purpurea gene encoding dimethylallyltryptophan synthase, the committed step for ergot alkaloid biosynthesis. Biochem Biophys Res Commun 1995, 216:119-125.
112. Tudzynski P., Scheffer J. Claviceps purpurea: molecular aspects of unique pathogenic lifestyle. Mol Plant Pathol 2004, 5:377-388.
113. Tudzynski P., Hölter K., Correia T., Arntz C., Grammel N., Keller U. Evidence for an ergot alkaloid gene cluster in Claviceps purpurea. Mol Gen Genet 1999, 261:133-141.
114. Tudzynski P., Correia T., Keller U. Biotechnology and genetics of ergot alkaloids. Appl Microbiol Biotechnol 2001, 57:593-605.
115. Tulasne L.R. Mémoire sur l'ergot des glumacées. Ann Sci Nat Bot 1853, 3:5-56.
116. Wallwey C., Li S.M. Ergot alkaloids: structure diversity, biosynthetic gene clusters and functional proof of biosynthetic genes. Nat Prod Rep 2011, 28:496-510.
117. Walzel B., Riederer B., Keller U. Mechanism of alkaloid cyclopeptide formation in the ergot fungus Claviceps purpurea. Chem Biol 1997, 4:223-230.
118. Wang J., Machado C., Panaccione D.G., Tsai H.F., Schardl C.L. The determinant step in ergot alkaloid biosynthesis by an endophyte of perennial ryegrass. Fungal Genet Biol 2004, 41:189-198.
119. Williams M.E. Genetic engineering for pollination control. Trends Biotech 1995, 13:344-349.